The effect of vitamin C on flu-like syndrome in MS patient

The effect of vitamin C on flu-like syndrome in MS patient after starting beta-interferon

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190731044396N1

Enrollment

100

Registered

2019-10-02

Start date

2019-08-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FLS in MS Pt that receives beta interferon.

Interventions

Intervention 1: Intervention group: administration of daily Vit C (250mg) for 3 months. Intervention 2: Control group: administration of daily placebo tablets for 3 months.

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: MS patients based on the McDonald's 2017 Criterion, taking interferon for the first time.

Exclusion criteria

Exclusion criteria: A patient with MS who has been on the interferon therapy for some time Patients who do not wish to participate in the study.

Design outcomes

Primary

Measure	Time frame
Fever and chills, weakness, muscle body pain. Timepoint: first, second and third months. Method of measurement: flu like syndrome symptoms score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Poursadeghfard

Shiraz University of Medical Sciences

Poursadegh@sums.ac.ir+98 71 3612 1065

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026